Event
DPHARM 2025
September 16 - September 17, 2025
Philadelphia, Penn.
DPHARM (Disruptive Innovations to Advance Clinical Research) is the leading event for transforming clinical trials through innovation. Now in its 15th year, the DPHARM®️ Annual Conference brings together over 800 clinical operations professionals, senior executives, and forward-thinking leaders to explore the latest breakthroughs in modernizing clinical research.
This year’s event will challenge the industry to reimagine the future of clinical trials by 2030, featuring real-world examples from organizations already driving change. Attendees will gain valuable insights into how R&D innovation is improving efficiency, accelerating timelines, and ultimately benefiting patients.
Visit Parexel at Booth #200 in the exhibit hall—we’ll be onsite to connect, answer your questions, and discuss how we can support your clinical development needs. Want to ensure time with our team? Schedule a meeting in advance using the link below.
Join several Parexel senior leadership executives on September 16th for a Panel discussion, patient keynote, and an Innovative Sources and solutions track.
Peyton Howell
Chief Executive Officer
September 16 from 8:25 – 8:55 a.m.
Title – Expanding Your Global Footprint for Clinical Research: Readiness to Pivot
Moderator: Penny Carlson, VP, Head of Global Clinical Development Operations, Takeda
Panelists:
- Peyton Howell, CEO, Parexel
- Nikki Amaratunge, VP, Clinical Development Operations, Head of Clinical Site Management, AbbVie
- Melika Davis, SVP, Global Clinical Operations, BeOne Medicines
- David Carruthers, VP, Pharmaceutical R&D Clinical Operations, AstraZeneca
- Marta Arias-Salgado, VP, Global Head GCTO Regions and Regional Operations, Merck & Co., Inc.
Charlotte Moser, M.D., Ph.D., M.B.A.
Chief Medical Officer
September 16 from 8:05 – 8:25 a.m.
Title – Patient Keynote
As patient advocate and the first CRISPR Gene Therapy recipient for Sickle Cell Anemia, Victoria Gray will share her incredible story of battling the disease and the life-changing impact of CRISPR therapy.
Speakers:
- Charlotte Moser, MD, PhD, MBA, Chief Medical Officer, Parexel (moderator)
- Victoria Gray, Advocate and First CRISPR Gene Therapy Recipient for SCD at NA
Request a meeting
Are you interested in meeting with our experts at this event? Please fill out the form below, and we'll contact you with more details.